Use patents can be useful: The case of rescued drugs

Science Translational Medicine

Volumn 6, Issue 248, 2014, Pages

  Rai, Arti K ^a   Rice, Grant ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG APPROVAL; DRUG INDUSTRY; DRUG REPOSITIONING; HUMAN; PATENT; TRANSLATIONAL RESEARCH;

DRUG APPROVAL; DRUG INDUSTRY; DRUG REPOSITIONING; HUMANS; PATENTS AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84905974197     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009120     Document Type: Short Survey

References (10)

1. B. N. Roin, Unpatentable drugs and the standards of patentability. Texas Law Rev. 87, 503-570 (2009).
2. A. Rai, Use patents, carve-outs, and incentives - A new battle in the drug-patent wars. N. Engl. J. Med. 367, 491-493 (2012).
3. A. Kapczynski, C. Park, B. Sampat, Polymorphs and prodrugs and salts (oh my!): An empirical analysis of "secondary" pharmaceutical patents. PLOS One 7, e49470 (2012).
4. M. J. Barratt, D. E. Frail, Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs (Wiley, New York, 2012).
5. M. Lanthier, K. L. Miller, C. Nardinelli, J. Woodcock, An improved approach to measuring drug innovation finds steady rates of fi rst-in-class pharmaceuticals, 1987-2011. Health Af. 32, 1433-1439 (2013).
6. R. B. Smith, Repositioned drugs: Integrating intellectual property and regulatory strategies. Drug Discov. Today Ther. Strateg. 8, 131-137 (2011).
7. C. S. Hemphill, B. N. Sampat, When do generics challenge drug patents. J. Empirical Legal Studies 8, 613-649 (2011).
8. S. M. Paul, D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos, S. R. Lindborg, A. L. Schacht, How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214 (2010).
9. A. M. Thayer, Drug repurposing. Chem. Eng. News 90, 15-25 (2012).
10. A. K. Rai, J. H. Reichman, P. F. Uhlir, C. Crossman, Pathways across the valley of death: Novel intellectual property strategies for accelerated drug discovery. Yale J. Health Policy Law Ethics 8, 1-36 (2008).